Manulife (Manufacturers Life Insurance)
RNTX

Manulife (Manufacturers Life Insurance)’s Rein Therapeutics RNTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-28
Closed -$3K – 3917
2018
Q2 		$3K Hold
28
– – ﹤0.01% 4173
2018
Q1 		$4K Sell
28
-36
-56% -$6.42K ﹤0.01% 4166
2017
Q4 		$14K Buy
64
+34
+113% +$8.15K ﹤0.01% 3900
2017
Q3 		$8K Buy
+30
New +$7.53K ﹤0.01% 3918

Other funds holding RNTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RNTX Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Rein Therapeutics (RNTX) in Q3 2018, closing a stake of 28 shares — an estimated $3K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RNTX in Q3 2017 and held it in 4 quarters. The position peaked at $14K in Q4 2017. 23 funds tracked by Wall St. Rank hold RNTX as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Rein Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 28 Rein Therapeutics shares in Q3 2018, an estimated $3K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Rein Therapeutics in Q3 2017 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Rein Therapeutics position peaked at $14K in Q4 2017.
  • 23 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.